Literature DB >> 2753050

Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells.

J C Maublant1, N Moins, P Gachon.   

Abstract

Two new neutral lipophilic 99mTc labeled molecules, chloro (methylboron (1-)-tris[1,2-cyclohexane-dionedioxime (1-)]-N,N',N'',N''',N'''',N''''') (SQ 30217) and Bis [1,2-cyclohexanedione dioximato (1-)-0]-[1,2-cyclohexane-dione dioximato (2-)-0] borato (2-N,N',N'',N''',N'''',N''''')-chloro Tc (SQ 32014), were studied in cultures of beating myocardial cells of newborn rats. The uptake and release kinetics, the effects of various pH levels of the medium, and the effects of three metabolic inhibitors, i.e., ouabain, cyanide and iodoacetate were assessed. Results show that T1/2 of uptake were less than 2 min with both tracers, and T1/2 of release were 12 and 13 min with SQ 32014 and SQ 30217, respectively. The intra/extracellular tracer concentrations was about 15 times higher with SQ 30217 than with SQ 32014. Intracellular concentration was decreased for both tracers at high pH levels, and was only moderately modified otherwise, including in the presence of the metabolic inhibitors. It is concluded that both tracers present very interesting properties for myocardial blood flow imaging, although a higher contrast should be expected with SQ 30217 than with SQ 32014.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753050     DOI: 10.1007/bf00253790

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  4 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells.

Authors:  J C Maublant; P Gachon; N Moins
Journal:  J Nucl Med       Date:  1988-01       Impact factor: 10.057

3.  Thallium-201 for medical use. II: Biologic behavior.

Authors:  P R Bradley-Moore; E Lebowitz; M W Greene; H L Atkins; A N Ansari
Journal:  J Nucl Med       Date:  1975-02       Impact factor: 10.057

4.  Thallium-201 for medical use. Part 3: Human distribution and physical imaging properties.

Authors:  H L Atkins; T F Budinger; E Lebowitz; A N Ansari; M W Greene; R G Fairchild; K J Ellis
Journal:  J Nucl Med       Date:  1977-02       Impact factor: 10.057

  4 in total
  9 in total

Review 1.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

2.  Assessment of myocardial perfusion with Tc-99m: image is everything.

Authors:  Seth T Dahlberg
Journal:  J Nucl Cardiol       Date:  2009-04-30       Impact factor: 5.952

3.  Assessment of reperfusion after acute myocardial infarction: is there a role for acute technetium 99m-teboroxime imaging?

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952

Review 4.  Myocardial kinetics of radiolabeled perfusion agents: basis for perfusion imaging.

Authors:  S T Dahlberg; J A Leppo
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

5.  Myocardial uptake of thallium 201 and technetium 99m-labeled sestamibi after ischemia and reperfusion: comparison by quantitative dual-tracer autoradiography in rabbits.

Authors:  H Weinstein; C P Reinhardt; J F Wironen; J A Leppo
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

6.  Interaction of technetium 99m-labeled teboroxime with red blood cells reduces the compound's extraction and increases apparent cardiac washout.

Authors:  S T Dahlberg; M P Gilmore; J A Leppo
Journal:  J Nucl Cardiol       Date:  1994 May-Jun       Impact factor: 5.952

7.  Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent.

Authors:  Padmaja Yalamanchili; Eric Wexler; Megan Hayes; Ming Yu; Jody Bozek; Mikhail Kagan; Heike S Radeke; Michael Azure; Ajay Purohit; David S Casebier; Simon P Robinson
Journal:  J Nucl Cardiol       Date:  2007-10-22       Impact factor: 5.952

8.  Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium.

Authors:  G Johnson; I L Allton; K N Nguyen; J M Lauinger; D Beju; R Pasqualini; A Duatti; R D Okada
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952

9.  Myocardial clearance of technetium-99m-teboroxime in reperfused injured canine myocardium.

Authors:  David R Okada; Gerald Johnson; Robert D Okada
Journal:  EJNMMI Res       Date:  2014-08-01       Impact factor: 3.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.